AZD7442 Antibody and Bivalent COVID-19 Vaccine Are Well Tolerated in Immunocompromised Adults
A multicentre phase II trial found that co-administering the monoclonal antibody AZD7442 and a bivalent vaccine was well tolerated in ...
A multicentre phase II trial found that co-administering the monoclonal antibody AZD7442 and a bivalent vaccine was well tolerated in ...
Researchers designed three lipid nanoparticle mRNA vaccines targeting swine influenza hemagglutinin, finding that a swine-to-human antigen induced the broadest cross-reactive ...
A scientific review in Discover Nano highlights the therapeutic progress and ongoing translational hurdles facing lipid nanoparticle-mediated mRNA delivery systems ...
The National Institutes of Health has awarded a five-year, $57.5 million grant to Boston University's National Emerging Infectious Diseases Laboratories ...
A comprehensive review details how microneedle patches integrate solid-state stabilization, skin-targeted delivery, programmable booster dosing, and on-patient optical documentation into ...
A comprehensive review analyzes how microneedle arrays overcome biological barriers to deliver nucleic acids and gene-editing platforms directly into local ...
A new review synthesizes evidence that gut microbiota composition and metabolites such as short-chain fatty acids modulate immune responses to ...
A new review outlines how universal influenza vaccine platforms, from mRNA and viral vectors to adjuvanted inactivated vaccines, could broaden ...
A new review finds that mRNA vaccines and host-directed therapeutics for multidrug-resistant ESKAPE bacteria remain preclinical, with no licensed bacterial ...
An AI-guided lipid nanoparticle formulation remained functional after two months at 37 degrees Celsius or one year at room temperature ...
A new cross-platform review of eighteen FDA-approved RNA therapeutics finds that adverse effects depend more on delivery chemistry and administration ...
When COVID-19 vaccines first rolled out, pregnant women were largely left out of the original clinical trials, leaving them and ...
A Frontiers in Tropical Diseases Perspective argues that mRNA vaccine platforms should be treated as permanent preparedness infrastructure for Ebola ...
Australian researchers have completed the first head-to-head comparison of three mRNA-lipid nanoparticle vaccine platforms in human blood, revealing key differences ...
MIT chemical engineers have built an automated, self-correcting platform that rapidly produces lipid nanoparticles of precisely controlled sizes and shapes, ...
A new Science study shows that gut bacteria, particularly flagellin-producing Lachnospiraceae, and diet influence whether people develop fever after mRNA ...
New research shows that synthetic lipid nanoparticles trigger irregular calcium signals in cells partly through the pain-sensing ion channel TRPA1, ...
A new review in Materials Today Bio proposes a bottleneck-first framework for evaluating antigen delivery platforms in therapeutic cancer vaccines, ...
Chemists succeed in artificially manufacturing important building blocks for mRNA vaccines Chemists at Otto von Guericke University Magdeburg have, in ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.